0001654954-24-007462.txt : 20240606 0001654954-24-007462.hdr.sgml : 20240606 20240606182756 ACCESSION NUMBER: 0001654954-24-007462 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240606 DATE AS OF CHANGE: 20240606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cornell Alison A CENTRAL INDEX KEY: 0001549395 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40449 FILM NUMBER: 241026703 MAIL ADDRESS: STREET 1: 210 CARNEGIE CENTER CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zivo Bioscience, Inc. CENTRAL INDEX KEY: 0001101026 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870699977 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 E. LONG LAKE ROAD STREET 2: SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 BUSINESS PHONE: (248) 452 9866 MAIL ADDRESS: STREET 1: 21 E. LONG LAKE ROAD STREET 2: SUITE 100 CITY: BLOOMFIELD HILLS STATE: MI ZIP: 48304 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH ENHANCEMENT PRODUCTS INC DATE OF NAME CHANGE: 20040202 FORMER COMPANY: FORMER CONFORMED NAME: WESTERN GLORY HOLE INC DATE OF NAME CHANGE: 19991215 4 1 section16.xml FORM 4 X0508 4 2024-06-05 0001101026 Zivo Bioscience, Inc. ZIVO 0001549395 Cornell Alison A 362 MORNING GLORY LANE MARCO ISLAND FL 34145 true false false false Common Stock 2024-06-05 4 A false 60724 A 144578 D Common Stock 2024-06-05 4 A false 95134 7.96 A 239712 D Nonstatutory Stock Option to Purchase Common Stock 26.88 2024-06-05 4 D false 3179 D 2031-10-11 Common Stock 3179 0 D Nonstatutory Stock Option to Purchase Common Stock 21.66 2024-06-05 4 D false 2632 D 2032-07-27 Common Stock 2632 0 D Nonstatutory Stock Option to Purchase Common Stock 17.16 2024-06-05 4 D false 707 D 2032-12-15 Common Stock 707 0 D Nonstatutory Stock Option to Purchase Common Stock 15.66 2024-06-05 4 D false 23240 D 2032-12-18 Common Stock 23240 0 D Nonstatutory Stock Option to Purchase Common Stock 16.74 2024-06-05 4 D false 3626 D 2033-06-11 Common Stock 3626 0 D The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023. The canceled options were fully vested. The Issuer canceled options for an aggregate 33,384 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 7/28/2022, 12/16/2022, 12/19/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 60,724 shares of restricted stock. The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 6/12/2023 and vested as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2024 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date. /s/ Alison Cornell 2024-06-06